TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

Background: TP53 is frequently mutated in solid tumors, but its basic mutation mapping is mixed, particularly in aggressive-stage lung cancer. Experimental Design: We curated a total of 139 advanced non-small cell lung cancer (NSCLC) patients who harbored wild-type TP53 (TP53wt) or mutated TP53 (TP5...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Fang, Gu, Liyan, Zhong, Diansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599964/
https://www.ncbi.nlm.nih.gov/pubmed/36290859
http://dx.doi.org/10.3390/curroncol29100582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599964/
https://www.ncbi.nlm.nih.gov/pubmed/36290859
http://dx.doi.org/10.3390/curroncol29100582

Ejemplares similares